COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 364: Articles 3631-3640  | Next

Absence of SARS-CoV-2 in Wildlife of Northeastern Minnesota and Isle Royale National Park
Castaneda, D., Isaac, E. J., Kautz, T., Romanski, M. C., Moore, S. A., Aliota, M.
10.1101/2023.07.14.549077 — Posted: 2023-07-15
Environmental Surface Monitoring as a Noninvasive Method for SARS-CoV-2 Surveillance in Community Settings: Lessons from a University Campus Study
Ali, S., Cella, E., Johnston, C., Deichen, M., Azarian, T.
10.1101/2023.07.13.23292575 — Posted: 2023-07-14
Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern.
Davina-Nunez, C., Perez, S., Cabrera-Alvargonzalez, J. J., Rincon-Quintero, A., Treinta-Alvarez, A., Godoy-Diz, M., Suarez-Luque, S., Regueiro-Garcia, B.
10.1101/2023.07.14.549026 — Posted: 2023-07-14
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
Avila-Herrera, A., Kimbrel, J., Manuel Marti, J., Thissen, J., Saada, E., Weisenberger, T., Arrildt, K., Segelke, B., Allen, J., Zemla, A. K., Borucki, M. K.
10.1101/2023.07.14.549044 — Posted: 2023-07-14
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Ketaren, N. E., Mast, F. D., Fridy, P. C., Olivier, J. P., Sanyal, T., Sali, A., Chait, B. T., Rout, M. P., Aitchison, J.
10.1101/2023.07.14.549041 — Posted: 2023-07-14
Multivalent Exosome based protein vaccine: a "mix and match" approach to epidemic viruses' challenges.
Cacciottolo, M., Hsieh, L.-E., Li, Y., LeCalire, M. J., Nice, J. B., Twaddle, R., Mora, C. L., Young, M., Angeles, J., Lau, C., Jin, C., Elliott, K., sun, m.
10.1101/2023.07.13.548895 — Posted: 2023-07-14
A simulation framework for modeling the within-patient evolutionary dynamics of SARS-CoV-2
Terbot, J. W., Cooper, B. S., Good, J. M., Jensen, J. D.
10.1101/2023.07.13.548462 — Posted: 2023-07-14
Quantifying the impact of hospital catchment area definitions on hospital admissions forecasts: COVID-19 in England, September 2020 - April 2021
Meakin, S., Funk, S.
10.1101/2023.07.12.23292451 — Posted: 2023-07-13
Genetic Risk Factors for Severe and Fatigue Dominant Long COVID and Commonalities with ME/CFS Identified by Combinatorial Analysis
Taylor, K., Pearson, M., Das, S., Sardell, J., Chocian, K., Gardner, S.
10.1101/2023.07.13.23292611 — Posted: 2023-07-13
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild-to-Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial
Yotsuyanagi, H., Ohmagari, N., Doi, Y., Yamato, M., Nguyen, H. B., Bong, K. C., Imamura, T., Sonoyama, T., Ichihashi, G., Sanaki, T., Tsuge, Y., Uehara, T., Mukae, H.
10.1101/2023.07.11.23292264 — Posted: 2023-07-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).